Your DNA contains all of the information that makes you, you. With increasing understanding of the genetic basis of disease, the information in every cell may help anticipate, correct, or otherwise treat latent medical issues. The good news is that the cost of obtaining your personal DNA sequence is now less than the cost of a couple of concert tickets. At the same time, how is that information safeguarded? Who has access to it?  Can it be used to exclude you from insurance coverage or open the door to genetic discrimination?  Today’s guests are the CEO and CSO of Nebula Genomics.  CEO Kamal Obbad and CSO Dennis Grishin share their insights into the benefits of personalized sequencing, along with a discussion of how they mitigate risk of malicious dissemination and/or use of genetic data.

Follow Nebula Genomics on Twitter.
Follow Kamal Obbad on Twitter.
Follow Dennis Grishin on Twitter.
Here is the website for Nebula Genomics.

# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq

The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.